Docket HopperPart I · Bills · 119th H.R. 796
H.R. 796 · 119th CongressHealth

Second Chance for Moms Act has not moved since its introduction on Jan 28, 2025, with cosponsors, all Republicans

Sponsored by Miller, Mary E. R-IL · 13 cosponsors: 0 Democrats, 13 Republicans
IntroducedJan 28, 2025
Reported—
Passed one chamber—
Passed both—
Law—
What it changes · CRS summary

Written by the Congressional Research Service [2]. 64 words.

Second Chance for Moms Act of 2025 This bill requires labeling of the drug mifepristone to include certain information about the hormone progesterone and establishes a related telephone hotline. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.)

Context
Committees
House Energy and Commerce Committee
Policy area
Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
Sponsor
0 of 60 bills enacted since 2013
Text versions
1: introduced in house · 287 words
Subjects
AbortionConsumer affairsPrescription drugsSex and reproductive healthTelephone and wireless communicationWomen's health
Latest action
Jan 28, 2025: Referred to the House Committee on Energy and Commerce.
Records
Congress.gov · Bill text
Exhibit 1Passage odds band at each stage, rated when the bill reached it [4]
Related bills · 0

The bill status record lists no related bills.

Exhibit 2Articles naming the bill per day, last 90 days, US sources [3]